ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK)

HKD 5.36

(-1.83%)

Operating Expenses Summary of ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s latest annual operating expenses in 2023 was 365.05 Million CNY , down -4.61% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s latest quarterly operating expenses in 2024 Q2 was 80.16 Million HKD , down -0.15% from previous quarter.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported a annual operating expenses of 382.71 Million CNY in annual operating expenses 2022, up 73.63% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported a annual operating expenses of 220.41 Million CNY in annual operating expenses 2021, down 0.0% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported a quarterly operating expenses of 80.16 Million HKD for 2024 Q2, down -0.15% from previous quarter.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported a quarterly operating expenses of 207.13 Million HKD for 2023 Q4, up 74.77% from previous quarter.

Annual Operating Expenses Chart of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2023 - 2021)

Historical Annual Operating Expenses of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2023 - 2021)

Year Operating Expenses Operating Expenses Growth
2023 365.05 Million CNY -4.61%
2022 382.71 Million CNY 73.63%
2021 220.41 Million CNY 0.0%

Peer Operating Expenses Comparison of ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD -12.309%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD 50.618%